Thromboembolism Global Clinical Trials Review, H1, 2012

GlobalData, May 2012, Pages: 110

Thromboembolism Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2012" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Thromboembolism Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Thromboembolism , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Thromboembolism
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Thromboembolism
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Thromboembolism Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bayer AG
Clinical Trial Overview of Bayer AG
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Sanofi
Clinical Trial Overview of Sanofi
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Daiichi Sankyo Company, Limited
Clinical Trial Overview of Daiichi Sankyo Company, Limited
Intermountain Healthcare, Inc.
Clinical Trial Overview of Intermountain Healthcare, Inc.
LEO Pharma A/S
Clinical Trial Overview of LEO Pharma A/S
L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Clinical Trial Overview of L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
ThromboGenics NV
Clinical Trial Overview of ThromboGenics NV
Daiichi Sankyo, Inc.
Clinical Trial Overview of Daiichi Sankyo, Inc.
Portola Pharmaceuticals, Inc.
Clinical Trial Overview of Portola Pharmaceuticals, Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Bayer Inc.
Clinical Trial Overview of Bayer Inc.
Rovi Pharmaceuticals Laboratories
Clinical Trial Overview of Rovi Pharmaceuticals Laboratories
MEDRAD Interventional/POSSIS
Clinical Trial Overview of MEDRAD Interventional/POSSIS
Gardia Medical Ltd.
Clinical Trial Overview of Gardia Medical Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Ottawa Hospital Research Institute
Clinical Trial Overview of Ottawa Hospital Research Institute
Brigham and Women's Hospital
Clinical Trial Overview of Brigham and Women's Hospital
University of Padua
Clinical Trial Overview of University of Padua
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
McMaster University
Clinical Trial Overview of McMaster University
Beijing Chao Yang Hospital
Clinical Trial Overview of Beijing Chao Yang Hospital
St. Orsola Hospital
Clinical Trial Overview of St. Orsola Hospital
Utrecht University
Clinical Trial Overview of Utrecht University
University of Calgary
Clinical Trial Overview of University of Calgary
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
University of Pennsylvania
Clinical Trial Overview of University of Pennsylvania
Hopitaux Universitaires de Geneve
Clinical Trial Overview of Hopitaux Universitaires de Geneve
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Centre Hospitalier Universitaire de Saint Etienne
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
The University of Utah
Clinical Trial Overview of The University of Utah
Azienda Ospedaliera Universitaria Policlinico catania
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania
Università degli Studi dell'Insubria
Clinical Trial Overview of Università degli Studi dell'Insubria
University Hospital, Brest
Clinical Trial Overview of University Hospital, Brest
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, BRIC Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, G7 Countries, 2012-
Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Clinical Trials, E7 Countries, 2012-
Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Thromboembolism Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Thromboembolism Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Intermountain Healthcare, Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A.L Clinica Pesquisa e Desenvolvimento Ltda., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Portola Pharmaceuticals, Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer Inc., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rovi Pharmaceuticals Laboratories, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by MEDRAD Interventional/POSSIS, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Gardia Medical Ltd., 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Padua, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Chao Yang Hospital, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Università degli Studi dell'Insubria, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012-
Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012-

List of Figures
Thromboembolism Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Thromboembolism Therapeutics Clinical Trials, G7 Countries (%), 2012-
Thromboembolism Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Clinical Trials, E7 Countries (%), 2012-
Thromboembolism Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Thromboembolism Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Thromboembolism Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Global Thromboembolism Drug Pipeline Capsule - 2011
• Global Thromboembolism Drug Pipeline Capsule - 2012
• Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism
• Cholangitis Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Otitis Media Global Clinical Trials Review, H2, 2012
• Strabismus Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012
• Anal Fissure Global Clinical Trials Review, H1, 2013
• Keratitis Global Clinical Trials Review, H2, 2012